Dana Farber Cancer Institute, Inc.

Boston, Massachusetts 02115

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Breast Cancer

Studies at this site

• A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer — Completed